Casado MPR, López LR

Language: Spanish
References: 15
Page:
PDF size: 130.34 Kb.

ABSTRACT

In order to value the quantitative risks of the ischemic cardiopathy there have been created risk tables, like the ones approved by the World Health Organization. With the objective to evaluate the cardiovascular global risk in the population of the health area #33 of Cauto Cristo it was performed a quantitative, explanatory, experimental, clinical assay to be evaluated in the University Polyclinic “Joel Benitez”, since December 1rst 2010 to November 30, 2011. The universe was made by 937 patients with a prevalence of the female sex (53.68%). The average age was about 56.6 years old. The 5.02% suffered from diabetes mellitus. 79.9% practices smoking. 63.04% of patients suffer from hypercholesterolemia. The 55% is carrier of obesity/overweight and the 56.9% carries an elevated amount of systolic blood pressure. The cardiovascular global risk according to Gaziano was statistically outstanding and similar to the calculus by the approved charts of the World Health Organization. It was recommended then to use Gaziano charts for the systemic calculation of the cardiovascular global risk for every kind of population.

REFERENCES

1. MINSAP. Anuario Estadístico del Ministerio de Salud Pública de Cuba; 2010.

2. Liu J, Grundy S, Wang W, Smith S, Vega G, Wu Z. Ten years risk of cardiovascular incidence related to diabetes, prediabetes and the metabolic syndrome. Am Heart J. 2007; 153(4):552-8.

3. Chatelier G, Colombet I. Use of absolute cardiovascular risk to guide decisions or the arrangement of cardiovascular risk factors: potential and limitations. Medicographica. 2001; 20(3):209-10.

4. Wood D. Prevention of coronary heart disease in clinical practice. Recommendation of the Second Joint Task Force of European and Other Societies on Coronary Prevention. Eur Heart J. 2002; 19: 1434-46.

5. Multiple Risk Factors Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the multiple risk factor intervention trial findings related to a priori hypotheses of the trial. J Am Med Assoc 2003:1795-80.

6. D´Agostino R, Grundy S, Sullivan L. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286:180-7.

7. Menotti A, Puddu P, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21:365-70.

8. Hensen HW, Schulte H, Lowel H. Framingham Risk function overestimates risk of coronary heart disease in men and women from Germany. Results from the MONICA Ausburg cohort and the PROCAM cohort. Eur Heart J 2003; 24:937-45.

9. Cabalé Vilariño MB, Meneau X, Núñez M. Incidencia de las dislipidemias y su relación con la cardiopatía isquémica en la población del Policlínico "Héroes del Moncada". Rev Cubana Med Gen Integr [Internet] 2005 [citado 22 enero 2011]; 21(5): [aprox. 6p.]. Disponible en: http://www.bvs.sld.cu/revistas/mgi/vol21_5- 6_05/mgi025-605.htm

10. Non-laboratory-based prediction of cardiovascular risk. The Lancet 2008; 371; (9616): 923-931.

11. Dasinger M, Gleason J, Griffith J, Selker H, Schaefer E. Comparison of the Atkins, Ormish, weight matches and zone diets for weigth loss and heart disease risk reduction. JAMA 2005; 293:43-53.

12. Pérez B, Cano I, Ballesteros M, Aguado R. Dietas bajas en hidratos de carbono frente a dietas bajas en grasas. Rev Endocrinol Esp 2006; 53(3):209-17.

13. Nassiff A, Meriño E. Ácidos grasos omega 3: pescados de carne azul y concentrados de aceite de pescado. Lo bueno y lo malo. Rev Cub Med [Internet] 2003 [citado 22 enero 2011]; 42(2): [aprox. 4p.]. Disponible en: http://bvs.sld.cu/revistas/med/vol42_2_03/med08203.htm

14. Prevención de las enfermedades cardiovasculares. Guía de bolsillo para la estimación y manejo del riesgo cardiovascular. Ginebra: Organización Mundial de la Salud; 2008.

15. Howard B, Best L, Galloway J, James W, Jones K, Lee E, et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006; 29: 391-7.